Opendata, web and dolomites

BQ-Technology

BrainQ, non-invasive, very low intensity, BCI-based frequency dependent electromagnetic field tailored treatment for neuro recovery (BQ).

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 BQ-Technology project word cloud

Explore the words cloud of the BQ-Technology project. It provides you a very rough idea of what is the project "BQ-Technology" about.

neurological    scalable    time    waves    populations    sensor    anomalous    linked    neural    animal    causes    natural    trials    patient    device    aging    death    operator    frequencies    recovery    impairments    patterns    continue    first    interface    strokes    electromagnetic    cognitive    impaired    easily    globally    burden    neuro    revolutionary    spectral    attributable    functional    rehabilitation    age    care    cloud    infections    healthcare    remarkable    prevalence    brain    viral    dementia    deficits    restore    operated    clinical    efficacy    designed    daily    stroke    frequency    translated    agnostic    sensorimotor    risk    back    living    eeg    global    perform    bill    invasive    treatment    indication    connected    55    doubles    algorithms    intelligence    uses    treat    stimulation    proprietary    paralysed    computer    decreased    disorders    skills    feet    disability    dependent    injuries    motor    regain    triggers    mortality    network    materials    decade    patients    variety    world    human    artificial    brainq    bq    demonstrated   

Project "BQ-Technology" data sheet

The following table provides information about the project.

Coordinator
BRAINQ TECHNOLOGIES LTD 

Organization address
address: 4/4 HIGH TECH VILLAGE GIVAT RAM
city: JERUSALEM
postcode: 39129
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website http://brainqtech.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-08-01   to  2018-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BRAINQ TECHNOLOGIES LTD IL (JERUSALEM) coordinator 50˙000.00

Map

 Project objective

The WHO has identified neurological disorders as a major burden and emerging challenge to global healthcare systems. These range from causes such as stroke and dementia, to injuries and viral infections. The prevalence of strokes and dementia are strongly linked to increasing age, for example stroke risk more than doubles every decade after 55 . Although, mortality attributable to stroke has decreased over time Stroke remains a leading cause of death and disability globally and can cause significant deficits in sensorimotor skills and cognitive abilities.

With the increasingly aging populations across the world and particularly in Europe, the burden of care from Neurological disorders is set to continue increasing.

BrainQ’s BQ system is a revolutionary Brain Computer Interface-based stimulation device used to enhance neuro-recovery. Our device uses proprietary, artificial intelligence algorithms to identify anomalous spectral patterns in patient's brain waves (“EEG”). These patterns are then translated into a tailored frequency dependent electromagnetic treatment targeting specific impaired functional neural network associated with these frequencies and triggers natural rehabilitation thus promoting neuro recovery process.

Device is designed to enable non-invasive treatment for motor impairments following a variety of neurological disorders; help patients get back on their feet and restore their ability to perform activities of daily living. Treatment is tailored to each patient, is patient friendly, non-invasive, cloud connected & scalable, with low Bill of Materials, and operator & indication agnostic. This means it is easily operated and can be used to treat a variety of neurological disorders. Pre-clinical animal trials and first-in-human clinical trials have demonstrated remarkable efficacy, allowing paralysed patients regain sensor and motor abilities.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BQ-TECHNOLOGY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BQ-TECHNOLOGY" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

CAARESYS (2019)

CAARESYS: vehicle passenger monitoring system based on contactless low emission radio frequency radar.

Read More